En

IUPAC-Richter Prize in Medicinal Chemistry

2022 IUPAC-Richter Prize in Medicinal Chemistry - Call for Nominations

The 2022 IUPAC-Richter Prize will be presented during the 37th ACS National Medicinal Chemistry Symposium (June 26-29, 2022) in New York (USA) and the recipient will also give a lecture on the subject of his/her/ research at the XXVII EFMC International Symposium on Medicinal Chemistry (September 4-8, 2022) in Nice (France).

The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.

Prize USD 10 000

The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc.  (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health.

Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional autobiography of not more than two pages, and a one-page summary of what the individual considers to be his/her activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.

For further information please  contact Prof. Janos Fischer, Chairman of the IUPAC Sub-committee on Drug Discovery and Development, by email at 

Nomination materials should be uploaded by 15 December 2021 to IUPAC Secretariat via the following form.

Telephone: +1 (919) 485 8700
Fax: +1 (919) 485 8706

John Macor awardee of the 2020 IUPAC - RICHTER PRIZE

John Macor has been selected as awardee of the 2020 IUPAC-Richter Prize in recognition of his research work affording new drugs for the treatment of migraine. The acceptance lecture will be held in Basel, Switzerland in September 2021 at the XXVI European Federation of Medicinal Chemistry International Symposium on Medicinal Chemistry (EFMC-ISMC) and a second lecture at the 37th ACS National Medicinal Chemistry Symposium to be held in New York.

This  year marks the eighth occassion of the IUPAC-Richter Prize, which was established in 2005 by IUPAC (International Union of Pure and Applied Chemistry) and Richter PLC. Awarded biannually, the awardee is announced by IUPAC following nominations and the decision of an indepedent international Selection Committee. According to the rules of the prize the awardee is expected to give two lectures,  one in Europe and one in the United States, at international symposiums on medicinal chemistry. The lecture in which the prize is awarded occurs alternatively in Europe and in the United States.

The awardee receives $10 000, which is sponsored by Richter PLC,  and a plaque, which is presented by IUPAC.

The previous awardees were :

  • 2006 : Malcolm FG Stevens (UK)
  • 2008: Jan Heeres (Belgium)
  • 2010 : Arun Ghosh (USA)
  • 2012 : Stephen Hanessian (Canada)
  • 2014 : Helmut Buschmann (Germany)
  • 2016 : Michael Sofia (USA)
  • 2018 : Peter Grootenhuis (USA)